|
WO2010086351A1
|
|
3'-n-substituted 9-deoxo-9a-methyl-9a-aza-homoerythromycin having antimalarial activity
|
|
CN102378763A
|
|
Anti-inflammatory macrolide
|
|
WO2010015703A2
|
|
6 - o - substituted 15 -membered 8a- and 9a - lactams
|
|
WO2009130189A1
|
|
2'-o,3'-n-bridged macrolides
|
|
CN101809026A
|
|
9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a derivatives and their use for the treatment of malaria
|
|
GB0704940D0
|
|
Method to replace large eukaryotic genomic loci
|
|
US2006258600A1
|
|
Ether linked macrolides useful for the treatment of microbial infections
|
|
EP1879904A1
|
|
4" amino linked macrolides useful for the treatment of microbial infections
|
|
WO2007093840A2
|
|
Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
|
|
EP1846414A1
|
|
Tetracyclic monoamine reuptake inhibitors for treatment of cns diseases and disorders
|
|
EP1846428A1
|
|
Anti-inflammatory conjugates of macrolides and coumarins
|
|
EP1844053A2
|
|
Anti-inflammatory macrolide conjugates
|
|
EP1841776A2
|
|
Decladinosyl-macrolides with anti-inflammatory activity
|
|
US2008241959A1
|
|
Macrolide compounds containing biotin and photo-affinity group for macrolide target identification
|
|
EP1846003A1
|
|
9a-carbamoyl and thiocarbamoyl azalides with anti-inflammatory activity
|
|
EP1855696A2
|
|
9a-carbamoyl-y-aminopropyl- and 9a-thiocarbamoyl-y-aminopropyl-azalides with antimalarial activity
|
|
WO2006075256A2
|
|
9a-carbamoyl-ϝ-aminopropyl- and 9a-thiocarbamoyl-ϝ-aminopropyl-azalides with antimalarial activity
|
|
US2008227730A1
|
|
9A-Carbamoyl and Thiocarbamoyl Azalides With Antimalarial Activity
|
|
KR20070083811A
|
|
Conjugates with anti-inflammatory activity
|
|
CN1980945A
|
|
Carbamate linked macrolides useful for the treatment of microbial infections
|
